SCNI logo

Scinai Immunotherapeutics Ltd.

SCNI
Healthcare|Biotechnology|IL
$0.44
-0.01 (-2.22%)
DCF Value
$98.25
Tangible Book / Share
$0.21
Cash / Share
$0.05
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Oct 28, 2026 (F-3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Scinai Reports Significant Revenue Growth in First Nine Months of 2026 as CDMO Business Expands
Nov 5, 2026 · PRNewsWire
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing
Oct 20, 2026 · PRNewsWire
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
Oct 16, 2026 · PRNewsWire
Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement
Oct 14, 2026 · PRNewsWire
Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement
Oct 13, 2026 · PRNewsWire
Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement
Sep 21, 2026 · PRNewsWire
Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business
Sep 8, 2026 · PRNewsWire
Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum
Aug 24, 2026 · PRNewsWire
Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration
Aug 10, 2026 · PRNewsWire

SEC Filings (69)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 28, 2026F-3Shelf registrationDocumentIndex
Oct 20, 20266-KForeign issuer reportDocumentIndex
Oct 16, 20266-KForeign issuer reportDocumentIndex
Oct 15, 20266-KForeign issuer reportDocumentIndex
Oct 13, 20266-KForeign issuer reportDocumentIndex
Oct 5, 2026EFFECTDocumentIndex
Sep 24, 2026F-1IPO / offering registrationDocumentIndex
Sep 21, 20266-KForeign issuer reportDocumentIndex
Sep 8, 20266-KForeign issuer reportDocumentIndex
Aug 28, 2026EFFECTDocumentIndex
Aug 27, 2026POS AMDocumentIndex
Aug 26, 20266-KForeign issuer reportDocumentIndex
Aug 19, 20266-KForeign issuer reportDocumentIndex
Jul 9, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 1, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 17, 20266-KForeign issuer reportDocumentIndex
Jun 15, 20266-KForeign issuer reportDocumentIndex
Jun 8, 20266-KForeign issuer reportDocumentIndex
May 19, 2026EFFECTDocumentIndex
May 19, 2026424B3Offering prospectusDocumentIndex
May 12, 20266-KForeign issuer reportDocumentIndex
May 8, 2026F-3Shelf registrationDocumentIndex
May 8, 20266-KForeign issuer reportDocumentIndex
Apr 27, 20266-KForeign issuer reportDocumentIndex
Apr 1, 202620-FAnnual report (foreign)DocumentIndex
Mar 23, 20266-KForeign issuer reportDocumentIndex
Mar 19, 20266-KForeign issuer reportDocumentIndex
Feb 25, 20266-KForeign issuer reportDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 20266-KForeign issuer reportDocumentIndex
Dec 23, 20256-KForeign issuer reportDocumentIndex
Dec 2, 20256-KForeign issuer reportDocumentIndex
Nov 13, 20256-KForeign issuer reportDocumentIndex
Nov 13, 20256-KForeign issuer reportDocumentIndex
Nov 12, 2025S-8Employee stock planDocumentIndex
Oct 6, 20256-KForeign issuer reportDocumentIndex
Oct 6, 2025424B3Offering prospectusDocumentIndex
Oct 1, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Sep 30, 2025EFFECTDocumentIndex
Sep 22, 2025F-1IPO / offering registrationDocumentIndex